Purchase Order 75D30124P19758
Award Date
9/17/24
Potential Completion Date
9/22/29
Potential Value
$115K
Federal Agency
CDC Pittsburgh
Awardee
Element Biosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $256,725 firm fixed price purchase order to Element Biosciences, Inc., a small disadvantaged business manufacturer of genetic analysis equipment and tools, for the delivery of an AVITI System next-generation DNA sequencing platform. The contract has a performance period ending on September 30, 2024 and does not utilize a small business set-aside. This award represents one of several federal contracts received by Element...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Element Biosciences, Inc., a small disadvantaged business based in San Diego, California. The contract is for the procurement of the AVITI System, a next-generation DNA sequencing platform, and associated sequencing kits and services. The contract has a ceiling value of $295,000.00 and a period of performance that extends through April 22, 2025. The contract does not utilize a...
This is a federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The $197,052.50 firm fixed price purchase order is for the delivery of lab equipment, with a performance period ending on August 31, 2027. Illumina has previously received prime contracts and subcontracts from various federal agencies, including the NIH, CDC, USDA, and VA, to...
This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention to Life Technologies Corporation, a for-profit provider of laboratory equipment and technologies for biomedical research and genetic analysis. The $118,049.95 firm fixed-price purchase order is for the delivery of unspecified laboratory equipment. The contract has no set-aside designation and was awarded on August 22, 2017, with a completion date of August 29, 2018. As a...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a division of Thermo Fisher Scientific, for the purchase of laboratory equipment. The $83,423.10 firm fixed-price contract has an ultimate completion date of August 15, 2021 and was awarded on July 13, 2021 without a set-aside designation. Life Technologies Corporation is the prime contractor for this award, which is part of a larger Indefinite Delivery Vehicle (IDV)...
This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price for $153,850.00 and a completion date of September 30, 2020. The contract does not have a set-aside designation. Life Technologies Corporation, a division of Thermo Fisher Scientific, provides...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to facilitate the relocation of equipment to accommodate COVID-19 (CORVD) operations. The $20,092.00 contract has an ultimate completion date of August 1, 2024. Illumina has a history of providing sequencing systems and associated services to support genomic research and diagnostics across various...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a for-profit manufacturer of sequencing and array-based genomic analysis solutions. The $98,094.00 contract is for the provision of laboratory equipment, with no set-aside designation. Based on Illumina's past federal contract work, the equipment is likely to include Next-Generation DNA sequencing systems, reagents, and related...
This is a firm fixed price contract award to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents, by the Centers for Disease Control and Prevention (CDC) for laboratory equipment. The contract has a ceiling value of $232,307.62 and a completion date of October 24, 2016. It is a Blanket Purchase Agreement (BPA) call, which suggests it is part of a larger contracting vehicle. Illumina has a history of providing sequencing systems, reagents, and bioinformatics...
This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a for-profit manufacturer of biomedical research and genetic analysis tools. The $160,678.75 firm fixed price purchase order is for the delivery of INTELLIFLEX EQUIPMENT with a completion date of August 31, 2022. The contract has no set-aside designation. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation,...